Governors Lane’s Bausch Health BHC Stock Holding History

Governors Lane’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-508,445	Closed	-$3.5M	–	129
2022 Q3	$3.5M	Buy	+508,445	New	+$3.53M	0.3%	104

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Governors Lane's BHC Position: Q4 2022 in Review

Governors Lane sold out of Bausch Health (BHC) in Q4 2022, closing a stake of 508,445 shares — an estimated $3.5M sold.

Governors Lane first reported a position in BHC in Q3 2022 and held it in 1 quarter. The position peaked at $3.5M in Q3 2022. 262 funds tracked by Wall St. Rank hold BHC as of Q4 2022.

Governors Lane reported no remaining Bausch Health position as of Q4 2022 after selling out during the quarter.
Governors Lane sold 508,445 Bausch Health shares in Q4 2022, an estimated $3.5M.
Governors Lane first reported a position in Bausch Health in Q3 2022 and held it in 1 quarter.
Governors Lane's Bausch Health position peaked at $3.5M in Q3 2022.
262 funds tracked by Wall St. Rank held Bausch Health as of Q4 2022.

Based on Governors Lane's 13F filing for Q4 2022, filed 14 Feb 2023.